Search Results - "Seminars in liver disease"
-
1
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Published in Seminars in liver disease (01-02-2019)“…Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from different etiologies, including hepatitis B and C and…”
Get more information
Journal Article -
2
Overview of microRNA biology
Published in Seminars in liver disease (01-02-2015)“…In considering an overview of microRNA biology, it is useful to consider microRNAs as a part of cellular communication. At the simplest level, microRNAs act to…”
Get more information
Journal Article -
3
Acetaminophen Hepatotoxicity
Published in Seminars in liver disease (01-05-2019)“…Acetaminophen (APAP) is one of the most popular and safe pain medications worldwide. However, due to its wide availability, it is frequently implicated in…”
Get more information
Journal Article -
4
Regression of Liver Fibrosis
Published in Seminars in liver disease (01-02-2017)“…Liver fibrosis is the final common pathway of chronic or iterative liver damage. Advanced chronic fibrosis is described as cirrhosis with a loss of…”
Get more information
Journal Article -
5
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Published in Seminars in liver disease (01-08-2018)“…The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV…”
Get more information
Journal Article -
6
NASH in Lean Individuals
Published in Seminars in liver disease (01-02-2019)“…Nonalcoholic fatty liver disease (NAFLD) is generally associated with obesity and the related comorbidities but it can also develop in subjects with a body…”
Get more information
Journal Article -
7
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Published in Seminars in liver disease (01-08-2015)“…The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease…”
Get more information
Journal Article -
8
Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis
Published in Seminars in liver disease (01-08-2020)“…Chronic liver injury due to viral hepatitis, alcohol abuse, and metabolic disorders is a worldwide health concern. Insufficient treatment of chronic liver…”
Get more information
Journal Article -
9
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions
Published in Seminars in liver disease (01-11-2012)“…The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly heterogeneous patient population and therefore poses unique challenges for…”
Get more information
Journal Article -
10
Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis
Published in Seminars in liver disease (01-05-2019)“…Endoplasmic reticulum (ER) stress is a major contributor to liver disease and hepatic fibrosis, but the role it plays varies depending on the cause and…”
Get more information
Journal Article -
11
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
Published in Seminars in liver disease (01-02-2010)“…The endpoint in cancer research is overall survival. Nonetheless, other potential surrogate endpoints, such as response rate and time to progression, are…”
Get more information
Journal Article -
12
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
Published in Seminars in liver disease (01-02-2020)“…Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction of small to medium size intrahepatic bile…”
Get more information
Journal Article -
13
Inflammasomes in Liver Fibrosis
Published in Seminars in liver disease (01-05-2017)“…Cell death and inflammation are two central elements in the development of liver fibrosis. Inflammasomes are intracellular multiprotein complexes expressed in…”
Get more information
Journal Article -
14
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Published in Seminars in liver disease (01-11-2021)“…The acronym nonalcoholic fatty-liver disease (NAFLD) groups a heterogeneous patient population. Although in many patients the primary driver is metabolic…”
Get more information
Journal Article -
15
Nonalcoholic Fatty Liver Disease in Children
Published in Seminars in liver disease (01-02-2018)“…Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who…”
Get more information
Journal Article -
16
Macrophages: master regulators of inflammation and fibrosis
Published in Seminars in liver disease (01-08-2010)“…Macrophages are found in close proximity with collagen-producing myofibroblasts and indisputably play a key role in fibrosis. They produce profibrotic…”
Get more information
Journal Article -
17
Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies
Published in Seminars in liver disease (01-08-2018)“…Portal vein tumor thrombosis (PVTT) commonly occurs in patients with hepatocellular carcinoma (HCC). Patients with PVTT usually have an aggressive disease…”
Get more information
Journal Article -
18
Liver Sinusoidal Endothelial Cell: An Update
Published in Seminars in liver disease (01-11-2017)“…This update focuses on two main topics. First, recent developments in our understanding of liver sinusoidal endothelial cell (LSEC) function will be reviewed,…”
Get more information
Journal Article -
19
Current strategy for staging and treatment: the BCLC update and future prospects
Published in Seminars in liver disease (01-02-2010)“…Staging and treatment indication are relevant topics in the management of patients with hepatocellular carcinoma (HCC) and for optimal results, they have to…”
Get more information
Journal Article -
20
Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP
Published in Seminars in liver disease (01-11-2013)“…The liver is a central organ that controls systemic energy homeostasis and nutrient metabolism. Dietary carbohydrates and lipids, and fatty acids derived from…”
Get more information
Journal Article